Journal article

Scientific Advances in Lung Cancer 2015.

  • Tsao AS Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Scagliotti GV San Luigi Hospital, University of Turin, Orbassano, Italy.
  • Bunn PA Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado.
  • Carbone DP Division of Medical Oncology, The Ohio State University, Columbus, Ohio.
  • Warren GW Department of Radiation Oncology, Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina.
  • Bai C Shanghai Respiratory Research Institute, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, People's Republic of China.
  • de Koning HJ Erasmus Medical Center, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands.
  • Yousaf-Khan AU Erasmus Medical Center, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands.
  • McWilliams A Fiona Stanley Hospital, Murdoch, Western Australia and University of Western Australia, Perth, Western Australia, Australia.
  • Tsao MS Department of Laboratory Medicine and Pathobiology, University Health Network and Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
  • Adusumilli PS Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rami-Porta R Department of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona, Barcelona, Spain; Centros de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) Lung Cancer Group, Terrassa, Barcelona, Spain.
  • Asamura H Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Van Schil PE Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem (Antwerp), Belgium.
  • Darling GE Division of Thoracic Surgery University of Toronto, Toronto, Canada.
  • Ramalingam SS Department of Hematology & Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Gomez DR Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Rosenzweig KE Department of Radiation Oncology at Icahn School of Medicine at Mount Sinai, New York, New York.
  • Zimmermann S Department of Oncology, HFR Fribourg, Fribourg, Switzerland.
  • Peters S Department of Oncology, University of Lausanne, Lausanne, Switzerland.
  • Ignatius Ou SH Chao Family Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Orange, California.
  • Reungwetwattana T Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Jänne PA Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Mok TS Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, People's Republic of China.
  • Wakelee HA Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, California.
  • Pirker R Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Mazières J Larrey Hospital, Paul Sabatier University, Toulouse, France.
  • Brahmer JR Johns Hopkins Kimmel Cancer Center, Johns Hopkins, Baltimore, Maryland.
  • Zhou Y Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Herbst RS Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut.
  • Papadimitrakopoulou VA Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Redman MW Fred Hutchinson Cancer Research Center, Public Health Sciences Division Seattle, Washington.
  • Wynes MW International Association for the Study of Lung Cancer, Aurora, Colorado.
  • Gandara DR Thoracic Oncology Program, UC Davis Comprehensive Cancer Center, Sacramento, California.
  • Kelly RJ Sidney Kimmel Comprehensive Cancer Center Johns Hopkins, Johns Hopkins, Baltimore, Maryland.
  • Hirsch FR Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado. Electronic address: Fred.Hirsch@ucdenver.edu.
  • Pass HI Department of Cardiothoracic Surgery, New York University Langone Medical Center, New York, New York.
Show more…
  • 2016-03-26
Published in:
  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. - 2016
English Lung cancer continues to be a major global health problem; the disease is diagnosed in more than 1.6 million new patients each year. However, significant progress is underway in both the prevention and treatment of lung cancer. Lung cancer therapy has now emerged as a "role model" for precision cancer medicine, with several important therapeutic breakthroughs occurring during 2015. These advances have occurred primarily in the immunotherapy field and in treatments directed against tumors harboring specific oncogenic drivers. Our knowledge about molecular mechanisms for oncogene-driven tumors and about resistance to targeted therapies has increased quickly over the past year. As a result, several regulatory approvals of new agents that significantly improve survival and quality of life for patients with lung cancer who have advanced disease have occurred. The International Association for the Study of Lung Cancer has gathered experts in different areas of lung cancer research and management to summarize the most significant scientific advancements related to prevention and therapy of lung cancer during the past year.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/20298
Statistics

Document views: 93 File downloads:
  • Full-text: 0